2019年11月14日

去年引发种子轮后,健康催化剂资本管理再次引领创业的资金。分享肌肉骨骼数字医疗平台Risalto袋装700万美元的新资助卫生催化剂资本管理,启动昨日宣布。他们所做的这家总部位于纽约的公司使用人工智能发现肌肉和骨骼健康提供者在用户的区域。病人浏览这些选择通过公司的应用程序,它充当一个数字门房,帮助选择提示,适当照顾他们的身体状况。Risalto旨在与纳税人和供应商都合作,简化患者的护理。据该公司介绍,该平台已被证明,以减少病人的疼痛分数高达50%,影响成员的医疗选择95%的成功率。催化剂与健康资本管理公司,该公司拥有Oxeon风险工作室作为机构投资者。它除了融资平台本身的改进,Risalto说,这些新美元将帮助全国规模数字肌肉骨骼程序。“每天我们花与患者合作变得更加明显,缺乏协调和重要资源的MSK的问题,”博士丹尼尔·Pizzarello Risalto的创始人兼首席执行官,在一份声明中说。“我们与HCCM兴奋地继续我们的合作规模在全国范围内,帮助确保每个患者得到应有的关心,这样他们就可以避免危险的药物和不必要的手术。“市场快照昨日宣布的近一年半后出现Risalto 150万美元的种子,也是由资本管理健康的催化剂。 That same year saw fundings for similar concierge services addressing different areas of care, such as SteadyMD ( $2.5 million in March 2018 ) and Accolade ( $50 million in April 2018 ). Further, it was only two months ago that Firefly announced its $10.2 million Series A round , and the appointment of athenahealth’s former firebrand Jonathan Bush as its executive chairman. ON THE RECORD "Health Catalyst Capital has focused on MSK as a major pain point in the healthcare system. By investing a second time in Risalto Health as it transforms MSK care, Health Catalyst Capital is furthering its mission of improving healthcare system access and quality while lowering costs," Charles Boorady, founding managing director at Health Catalyst Capital Management, said in a statement. “We have been very impressed by the progress made by Dan and the team at Risalto since our last investment. We are excited now to support their scale-up and roll-out to employers and health plans nationally. " Tags: